Results 61 to 70 of about 22,329 (220)

Prevalence of Clarithromycin-Resistant Helicobacter pylori in Patients With Chronic Tonsillitis by Allele-Specific Scorpion Real-Time Polymerase Chain Reaction Assay [PDF]

open access: yes, 2013
Objectives/Hypothesis: To investigate the allelic prevalence of resistance to clarithromycin in the DNA of clinical isolates of Helicobacter pylori obtained from biopsy specimens of patients with chronic tonsillitis by Scorpion real-time polymerase ...
Johari, Pouran   +2 more
core  

Risk Factors For Multiple Sclerosis In Volyn Region (Ukraine) [PDF]

open access: yes, 2016
The prevalence rate of multiple sclerosis (MS) in Volyn Region (101.0 per 100000) is the highest in Ukraine. To study MS risk factors in Volyn Region, special questionnaires were distributed among all MS patients residing in Volyn region.
Bobryk, N. (Nataliia)   +1 more
core   +2 more sources

A Scoping Review of Recurrent Post‐Tonsillectomy Hemorrhage in Children

open access: yesThe Laryngoscope, Volume 136, Issue 5, Page 2026-2033, May 2026.
The goal of this scoping review was to analyze the incidence and risk factors for recurrent peritonsillar hemorrhage (PTH), and to map existing evidence to identify knowledge gaps. CINAHL, Cochrane Library, Embase, Google Scholar, and Ovid Medline were searched.
Kathleen R. Billings   +3 more
wiley   +1 more source

Correction of chronic tonsillitis as a component of pre-pregnancy preparation for primary miscarriage

open access: yesФундаментальная и клиническая медицина
Aim. To substantiate the effectiveness of conservative treatment of CT at the pre-pregnancy stage in order to reduce reproductive losses.Materials and Methods.
P. V. Filipeva   +6 more
doaj   +1 more source

Assessment of the cell-mediated immunity and il-4 and il-6 levels in children with chronic tonsillitis [PDF]

open access: yes, 2015
Хронічний тонзиліт є нагальною проблемою для педіатрів. По-перше, це викликано незрілістю імунної системи, зокрема, лімфатичної системи, в молодому віці.
Moschich, O.P.   +6 more
core  

Immune compromise in HIV-1/HTLV-1 coinfection with paradoxical resolution of CD4 lymphocytosis during antiretroviral therapy: a case report [PDF]

open access: yes, 2015
Human immunodeficiency virus type-1 (HIV-1) and human T lymphotropic virus type-1 (HTLV-1) infections have complex effects on adaptive immunity, with specific tropism for, but contrasting effects on, CD4 T lymphocytes: depletion with HIV-1, proliferation
Bangham, C   +6 more
core   +2 more sources

Adherence to Remote Prescribing Principles by Medical and Non‐Medical Prescribers; a Scoping Review

open access: yesJournal of Advanced Nursing, Volume 82, Issue 5, Page 4610-4624, May 2026.
ABSTRACT Aim To examine the extent of adherence to high‐level principles in remote prescribing and investigate how medical and non‐medical prescribers comply with these principles. Design Scoping Review. Data Sources A systematic search of CINAHL, PubMed, Medline, the Cochrane Database of Systematic Reviews, the Web of Science, and the Ovid Emcare ...
Michelle Lewington   +3 more
wiley   +1 more source

Clinical and laboratory peculiarities of acute myocardial infarction after chronic tonsillitis [PDF]

open access: yesСаратовский научно-медицинский журнал, 2012
Aim: The definition of the relationship of clinical and laboratory features of acute myocardial infarction depending on the suffering of chronic tonsillitis. Materials and methods. The study included 54 patients with acute myocardial infarction suffering
Shvarts Y.G., Dzhukaeva Kh.R.
doaj  

Assessment of Helicobacter pylori prevalence by scorpion real-time PCR in chronic tonsillitis patients

open access: yesJournal of Global Infectious Diseases, 2012
Background: Occasionally, bacteria or viruses enter the tonsils and these organs become overwhelmed by bacterial or viral infection leading to inflammation.
T Naserpour Farivar   +6 more
doaj   +1 more source

Efficacy and safety of brodalumab in palmoplantar pustulosis: A 68‐week randomized Phase 3 trial

open access: yesJournal of the European Academy of Dermatology and Venereology, Volume 40, Issue 5, Page 887-899, May 2026.
This open‐label study is a continuation of the 16‐week double‐blind, Phase 3 trial assessing the efficacy and safety of brodalumab 210 mg subcutaneously, till a 68‐week extension period. Continued improvement was seen in the PPPASI 50/75/90 responses, PPPSI scores, PGA 0/1 responses and DLQI. Abstract Background The efficacy and safety of brodalumab in
Masamoto Murakami   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy